Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Recruiting · NCT05745623 · Registry updated 2025-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors | Advanced Solid Tumors Harboring NTRK Fusion; Primary Central Nervous System Tumors Harboring NTRK Fusion | Recruiting | Phase 1 / Phase 2 | 2025-09-11 | NCT05745623 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing InnoCare Pharma Tech Co., Ltd. | 26 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |